Assignee
VLP THERAPEUTICS INC
US4 patents
Top patents by PatentIndex Score
US12280102B2Apr 22, 2025
Alphavirus replicon encoding chimeric SARS-CoV-2 receptor binding domains
VLP THERAPEUTICS INC0 citations60
US12227770B2Feb 18, 2025
Alphavirus replicon particle
VLP THERAPEUTICS INC0 citations60
US12134777B2Nov 5, 2024
Alphavirus replicon vector and immunotherapy by administering same
VLP THERAPEUTICS INC0 citations60
US11345726B2May 31, 2022
Chikungunya virus (CHIKV) or Venezuelan equine encephalitis virus (VEEV) virus-like particles comprising heterologous antigens inserted into the envelope protein
VLP THERAPEUTICS INC0 citations60